NO20065078L - Inhaleringspulver formuleringer inneholdende enantiomerisk rene beta-agonister. - Google Patents

Inhaleringspulver formuleringer inneholdende enantiomerisk rene beta-agonister.

Info

Publication number
NO20065078L
NO20065078L NO20065078A NO20065078A NO20065078L NO 20065078 L NO20065078 L NO 20065078L NO 20065078 A NO20065078 A NO 20065078A NO 20065078 A NO20065078 A NO 20065078A NO 20065078 L NO20065078 L NO 20065078L
Authority
NO
Norway
Prior art keywords
enantiomerically pure
powder formulations
formulations containing
beta agonists
inhalation powder
Prior art date
Application number
NO20065078A
Other languages
English (en)
Inventor
Michael Trunk
Jorg Schiewe
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35058202&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065078(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20065078L publication Critical patent/NO20065078L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Foreliggende oppfinnelse angår pulverformuleringer for inhalering inneholdende enantiomerisk rene forbindelser med den geneelle formel 1 hvor gruppene R1, R2, R3 og R4 kan ha betydningene angitt i kravene og i beskrivelsen, eventuelt i form av de farmasøytisk akseptable syreaddisjonssalter derav, samt eventuelt i kombinasjon med et farmasøytisk akseptabelt tilsetningsmiddel, fremgangsmåter for fremstilling av dem og anvendelse av dem som farmasøytiske preparater, spesielt som farmasøytiske preparater for behandling av respiratoriske lidelser.
NO20065078A 2004-05-14 2006-11-03 Inhaleringspulver formuleringer inneholdende enantiomerisk rene beta-agonister. NO20065078L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004024451A DE102004024451A1 (de) 2004-05-14 2004-05-14 Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
PCT/EP2005/005078 WO2005110359A1 (de) 2004-05-14 2005-05-11 Pulverformulierungen für die inhalation, die enantiomerenreine betaagonisten enthalten

Publications (1)

Publication Number Publication Date
NO20065078L true NO20065078L (no) 2006-11-28

Family

ID=35058202

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065078A NO20065078L (no) 2004-05-14 2006-11-03 Inhaleringspulver formuleringer inneholdende enantiomerisk rene beta-agonister.

Country Status (24)

Country Link
EP (1) EP1809236B1 (no)
JP (1) JP4891899B2 (no)
KR (1) KR101270449B1 (no)
CN (1) CN1984638A (no)
AR (1) AR048899A1 (no)
AU (1) AU2005244424B2 (no)
BR (1) BRPI0511136A (no)
CA (1) CA2565915C (no)
DE (1) DE102004024451A1 (no)
DK (1) DK1809236T3 (no)
EA (1) EA012582B1 (no)
ES (1) ES2401786T3 (no)
IL (1) IL179215A (no)
MX (1) MXPA06013221A (no)
MY (1) MY145838A (no)
NO (1) NO20065078L (no)
PE (1) PE20060239A1 (no)
PL (1) PL1809236T3 (no)
SG (1) SG152258A1 (no)
TW (1) TW200607508A (no)
UA (1) UA86807C2 (no)
UY (1) UY28896A1 (no)
WO (1) WO2005110359A1 (no)
ZA (1) ZA200607785B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
BRPI0614290A2 (pt) 2005-08-08 2011-03-22 Argenta Discovery Ltd derivados de biciclo [ 2.2.1 ] hept-7-ilamina e seus usos
CN101208316B (zh) * 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 制备β-模拟物的方法
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
ES2442343T3 (es) 2008-12-30 2014-02-11 Pulmagen Therapeutics (Inflammation) Limited Compuestos de sulfonamida para el tratamiento de trastornos respiratorios
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
JP2015533131A (ja) 2012-10-09 2015-11-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 咳を治療するためのベータ２−アドレナリン受容体作動薬
WO2018108669A1 (en) 2016-12-12 2018-06-21 Boehringer Ingelheim International Gmbh Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134590A1 (de) 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
BR0110331A (pt) * 2000-04-27 2003-01-07 Boehringer Ingelheim Pharma Substâncias que mimetizam beta que têm uma atividade de longa duração, processos para prepará-las e o uso das mesmas como medicamentos
GB0107106D0 (en) * 2001-03-21 2001-05-09 Boehringer Ingelheim Pharma Powder inhaler formulations
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
WO2005110359A1 (de) 2005-11-24
MY145838A (en) 2012-04-30
JP4891899B2 (ja) 2012-03-07
DK1809236T3 (da) 2013-02-11
AU2005244424A1 (en) 2005-11-24
DE102004024451A1 (de) 2005-12-22
PE20060239A1 (es) 2006-03-27
CA2565915A1 (en) 2005-11-24
KR20070016169A (ko) 2007-02-07
BRPI0511136A (pt) 2007-11-27
JP2007537195A (ja) 2007-12-20
UY28896A1 (es) 2005-12-30
IL179215A0 (en) 2007-03-08
EP1809236B1 (de) 2012-12-26
CN1984638A (zh) 2007-06-20
AR048899A1 (es) 2006-06-07
MXPA06013221A (es) 2007-02-08
EP1809236A1 (de) 2007-07-25
EA200602016A1 (ru) 2007-06-29
EA012582B1 (ru) 2009-10-30
KR101270449B1 (ko) 2013-06-04
ZA200607785B (en) 2008-07-30
TW200607508A (en) 2006-03-01
UA86807C2 (ru) 2009-05-25
AU2005244424B2 (en) 2010-12-23
CA2565915C (en) 2013-12-10
ES2401786T3 (es) 2013-04-24
IL179215A (en) 2011-04-28
PL1809236T3 (pl) 2013-05-31
SG152258A1 (en) 2009-05-29

Similar Documents

Publication Publication Date Title
MX340965B (es) Combinaciones para el tratamiento de enfermedades que involucran la proliferacion celular.
NO20065078L (no) Inhaleringspulver formuleringer inneholdende enantiomerisk rene beta-agonister.
WO2012007869A3 (en) N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
TW200736223A (en) N-(pyridin-2-yl)-sulfonamide derivatives
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
UA84896C2 (ru) Производные гидронопола как агонисты человеческих рецепторов orl1
TW200626553A (en) Novel compounds
MXPA05013050A (es) Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos.
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
UA84300C2 (ru) ПРОИЗВОДНЫЕ ГЕКСА- И ОКТАГИДРОПИРИДО[1,2-a]ПИРАЗИНА С АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ОТНОСИТЕЛЬНО NK1
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
MA32722B1 (fr) Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion
DE602006009556D1 (de) Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen
NO20063619L (no) Diarylmetylpiperazinderivater, fremstilling og anvendelse derav
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
NO20053805L (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application